Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q2Scopus Q1KCI Q1
- 저널
- Cancer Research and Treatment57(2) · pp.312 · 2025
- 피인용
- Web of Science 96Scopus 103KCI 13
- FWCI (Scopus)
- 22.3
- JCR IF
- JCR 2024 3.8
- ISSN
- 1598-2998
저자
- Park, Eun Hye제1저자National Cancer Control Institute, National Cancer Center, Goyang, Korea
- Jung, Kyu Won교신저자National Cancer Control Institute, National Cancer Center, Goyang, Korea
- Park, Nam JuNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- Kang, Mee JooNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- Hwa Yun, E.National Cancer Control Institute, National Cancer Center, Goyang, Korea
- Kim, Hye JinNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- Kim, Jeong EunNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- Kong, Hyun JooNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- Choi, Kui SonNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- Yang, Han KwangNational Cancer Control Institute, National Cancer Center, Goyang, Korea
- 김창훈(Busan Cancer Registry, Pusan National University Hospital)
- Yoo, Cheolin(Ulsan Cancer Registry, Ulsan University Hospital)
- Kim, Yong Dae(Chungbuk Cancer Registry, Chungbuk National University Hospital)
- Kim, Young Taek(Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital)
- Park, Kyung Ki(Jeju Cancer Registry, Jeju National University Hospital)
- Youm, Jung Ho(Chungbuk Cancer Registry, Chungbuk National University Hospital)
- Lim, Kyu Hyoung(Kangwon Cancer Registry, Kangwon National University Hospital)
- Shin, Ji Yeon(Daegu/Gyeongbuk Cancer Registry, Kyungpook National University Hospital)
- Kweon, Sun Seog(Gwangju/Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital)
- Kim, Hwan Cheol(Incheon Cancer Registry, Inha University Hospital)
- Park, Ki Soo(Gyeongnam Cancer Registry, Gyeongsang National University Hospital)
초록
Purpose The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2022, with international comparisons. Materials and Methods Cancer incidence, survival, and prevalence rates were calculated using the Korea National Cancer Incidence Database (1999-2022), with survival follow-up until December 31, 2023. Mortality data obtained from Statistics Korea, while international comparisons were based on GLOBOCAN data. Results In 2022, 282,047 newly diagnosed cancer cases (age-standardized rate [ASR], 287.0 per 100,000) and 83,378 deaths from cancer (ASR, 65.7 per 100,000) were reported. The proportion of localized-stage cancers increased from 45.6% in 2005 to 50.9% in 2022. Stomach, colorectal, and breast cancer showed increased localized-stage diagnoses by 18.1, 18.5, and 9.9 percentage points, respectively. Compared to 2001-2005, the 5-year relative survival (2018-2022) increased by 20.4 percentage points for stomach cancer, 7.6 for colorectal cancer, and 5.6 for breast cancer. Korea had the lowest cancer mortality among countries with similar incidence rates and the lowest mortality-to-incidence (M/I) ratios for these cancers. The 5-year relative survival (2018-2022) was 72.9%, contributing to over 2.59 million prevalent cases in 2022. Conclusion Since the launch of the National Cancer Screening Program in 2002, early detection has improved, increasing the diagnosis of localized-stage cancers and survival rates. Korea recorded the lowest M/I ratio among major comparison countries, demonstrating the effectiveness of its National Cancer Control Program.
키워드
식별자
- Scopus EID
- 2-s2.0-105003138691
- WoS UID
- 001473930500002
- KCI
- ART003193079



로그인
연구물 목록으로